BMY
2026Q2BMOBristol-Myers Squibb Company primary · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
Street
Consensus EPS1.59
Consensus rev—
EPS high—
EPS low—
Dispersion—
Analysts—
EPS rev net 7d—
EPS rev net 30d—
Consensus Δ 7d—
Consensus Δ 30d—
Options
Implied move1.7%
IV front—
P/C full—
P/C front—
Features as of2026-07-29
Run-up
Close—
Ret 5d+3.9%
Ret 10d+7.5%
Ret 20d+9.5%
Ret 30d+12.2%
Actual EPS
2.04Beat
Estimated EPS1.59
Actual revenue
13.0B
Surprise %+28.3%
Beat / missBeat
Beat streak 44
Beat streak 88
Reaction
1-day stock reaction+3.5%
Implied vs actual
Implied 1.7%Actual 0.6%
Gap reaction-0.6%
Day result+2.8%
Next-day upYes
Realized / IV0.39×
Post tape
Post 5d-1.1%
Post 10d-0.3%
Post volume18.0M
Vol ×10d1.75×
Vol ×20d1.73×
Post range5.3%